Toll Brothers
TOL
Meritage Homes
MTH
Taylor Morrison Home
TMHC
D.R. Horton
DHI
KB Home
KBH
US Stock MarketDetailed Quotes
AMRN Amarin
- 0.553
- +0.003+0.60%
Close Jan 8 16:00 ET
- 0.550
- -0.003-0.58%
Post 19:48 ET
227.59MMarket Cap-5.53P/E (TTM)
0.570High0.524Low1.37MVolume0.556Open0.550Pre Close756.74KTurnover0.36%Turnover RatioLossP/E (Static)411.34MShares1.37052wk High0.43P/B212.30MFloat Cap0.43052wk Low--Dividend TTM383.70MShs Float675.000Historical High--Div YieldTTM8.27%Amplitude0.430Historical Low0.552Avg Price1Lot Size
Amarin News
Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA), Bolt Biotherapeutics (BOLT) and Amarin (AMRN)
Amarin's Stock Maintains Hold Rating Amidst Revenue Highs and Market Challenges
Amarin's Sell Rating Upheld Amid Revenue Concerns and Market Access Challenges
Amarin Corp Analyst Ratings
Amarin's Sell Rating Affirmed Amid US Market Challenges and Uncertain European Growth
Amarin's Sell Rating Affirmed Amid Declining U.S. Sales and Uncertain International Expansion
Analysts Offer Insights on Healthcare Companies: Shockwave Medical (SWAV), Amarin (AMRN) and Mereo Biopharma Group Plc (MREO)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Tecan Group AG (OtherTCHBF) and Amarin (AMRN)
Amarin Corp Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Humana (HUM), Ocular Therapeutix (OCUL) and Amarin (AMRN)
Jefferies Downgrades Amarin Corp to Hold, Lowers Price Target to $1
Amarin Corp Analyst Ratings
Goldman Sachs Maintains Sell on Amarin Corp, Lowers Price Target to $1
Amarin Corp Analyst Ratings
Northland Capital Markets Maintains Market Perform on Amarin Corp, Lowers Price Target to $1.25
Amarin Corp Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Amarin (AMRN) and Myriad Genetics (MYGN)
Analysts Offer Insights on Healthcare Companies: Amarin (AMRN), Ascendis Pharma (ASND) and MoonLake Immunotherapeutics (MLTX)
SVB Securities Sticks to Their Hold Rating for Amarin (AMRN)
Analysts Offer Insights on Healthcare Companies: InMode (INMD), Fulcrum Therapeutics (FULC) and Amarin (AMRN)
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.